Drug Type Fusion protein |
Synonyms |
Target |
Mechanism DR3 agonists(Tumor necrosis factor receptor superfamily member 25 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Graft Rejection | Preclinical | US | - |